Alcaftadine
- Strength
- 2.5 mg/mL
- Form
- Solution/ Drops
- Class
- Histamine-1 Receptor Antagonist
Aurohealth LLC
Not stocked by us — reference only
LASTACAFT
alcaftadine
Listed by Allergan, Inc.
- Strength
- 2.5 mg/mL
- Form
- Solution/ Drops
- Route
- Ophthalmic
- Class
- Histamine-1 Receptor Antagonist
What it contains
- Alcaftadine 2.5 mg/mL
FDA record
| Dosage form | Solution/ Drops |
|---|---|
| Route | Ophthalmic |
| Drug class | Histamine-1 Receptor Antagonist |
| Approval route | NDA — original brand approval |
| NDC code | 0023-4291 |
| FDA application | NDA022134 |
| RxNorm concept | 1000085 |
| Package sizes listed | 5 |
| Marketed since | December 2021 |
Other products containing Alcaftadine
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Alcaftadine
- Strength
- 2.5 mg/mL
- Form
- Solution/ Drops
- Class
- Histamine-1 Receptor Antagonist
Gland Pharma Limited
Not stocked by us — reference only
alcaftadine
- Strength
- 2.5 mg/mL
- Form
- Solution/ Drops
- Class
- Histamine-1 Receptor Antagonist
Alembic Pharmaceuticals Inc.
Not stocked by us — reference only
LASTACAFT
alcaftadine
- Strength
- 2.5 mg/mL
- Form
- Solution/ Drops
- Class
- Histamine-1 Receptor Antagonist
Allergan, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.